Author | Lightnews

Psilocybin-Assisted Psychotherapy for End of Life Distress - OPEN Foundation

Reposted by PsyPal Project

PAREA @pareascience.bsky.social · Jun 24

We’re proud to be representing the PsyPal project @psypaleu.bsky.social at Psychedelic Science, in Denver, and at the European Academy of Neurology Congress, in Helsinki!

2 3

Reposted by PsyPal Project

PAREA @pareascience.bsky.social · Jun 13

🧠 One week until #EAN2025 in Helsinki!
We'll be there 21–24 June with a booth in the Neurohood + a session at the Scientific Theatre.

Come learn about the evolving frontier of psychedelic innovation in neurology, and about EU trial PsyPal (@psypaleu.bsky.social)! tinyurl.com/ean-session

1 2

PsyPal Project @psypaleu.bsky.social · Jun 3

PsyPal partners OPEN Foundation are running an open-access event to discuss psilocybin assisted therapy for end-of-life distress. This session is based on findings from a clinical trial in Australia and likely to be a very illuminating session!

Register here:
open-foundation.org/events/onlin...

Gain clinical insights from a groundbreaking Australian trial on psilocybin-assisted psychotherapy for end-of-life distress. Led by Dr. Margaret Ross and Dr. Justin Dwyer, this session explores how ps...

open-foundation.org

PsyPal Project @psypaleu.bsky.social · May 23

The creation of these guidelines brought together leading pharmacists, psychologists, psychiatrists & medical ethics experts. This sets the tone for more research into psychedelic therapies & greater interdisciplinary collaboration between these key groups at other national & international levels.

PsyPal Project @psypaleu.bsky.social · May 23

@psychedelicalpha.bsky.social reported on a landmark event at Champalimaud Foundation this month, where national clinical guidelines for psychedelic therapy for Portugal were proposed as an interdisciplinary collaborative effort.

psychedelicalpha.com/news/p%ce%b1...

1 1 1

PsyPal Project @psypaleu.bsky.social · May 6

This key event is taking place in Portugal next week. Watch this space- emerging from this may be a new roadmap for future national collaborations across Europe for developing multidisciplinary recommendations for clinical psychedelic use. @champalimaudf.bsky.social #PsychedelicSciSky

PAREA @pareascience.bsky.social · May 5

On May 12, the Champalimaud Foundation @champalimaudf.bsky.social will host the public presentation of multidisciplinary recommendations for the clinical use of psychedelics in Portugal. Check out the event here: tinyurl.com/cf-12may

This link will take you to a page that’s not on LinkedIn

PsyPal Project @psypaleu.bsky.social · May 2

3/ Findings based on both included trials suggest psilocybin may rapidly alleviate depressive and anxiety symptoms in cancer patients, however given the limited study numbers, caution and further research are advised. Read about the study here: lnkd.in/eSy-c5up
#psilocybintherapy #EUResearch

PsyPal Project @psypaleu.bsky.social · May 2

2/ Data from up to July 2024 included two randomized controlled trials, assessing Beck Depression Inventory (BDI) and State-Trait Anxiety Inventory (STAI) scores on day 1 and 2-week follow-up.

PsyPal Project @psypaleu.bsky.social · May 2

1/ A systematic review and network meta-analysis recently evaluated psilocybin's effectiveness in reducing depressive and anxiety symptoms among cancer patients.

This link will take you to a page that’s not on LinkedIn

PsyPal Project @psypaleu.bsky.social · Apr 24

Additionally, here is an editorial discussing spirituality in palliative care: Spirituality in Palliative Care editorial: bmcpalliatcare.biomedcentral.com/articles/10....

This link will take you to a page that’s not on LinkedIn

PsyPal Project @psypaleu.bsky.social · Apr 24

Read more about the work Hanneke and her team are undertaking for PsyPal here: www.trouw.nl/religie-filo...
This text is available in Dutch and on a subscription basis. We are keen to provide more insight into spiritual care within PsyPal on our website shortly!

PsyPal Project @psypaleu.bsky.social · Apr 24

Spiritual care is an integral part of PsyPal, with key work being done by Hanneke Muthert of University of Groningen. Addressing spiritual needs is considered a core tenet of palliative care - yet these needs are often underserved in practice (Quinn & Connolly, 2023).

PsyPal | 937 followers on LinkedIn. Horizon EU funded study of psilocybin to treat psychological distress in people requiring palliative care. | Horizon EU funded study of psilocybin to treat psycholo...

Reposted by PsyPal Project

PAREA @pareascience.bsky.social · Apr 21

Earlier this month, PAREA contributed to a @psypaleu.bsky.social workshop organised by @iese.bsky.social in Barcelona. The event gathered stakeholders to explore how psychedelics can be integrated into palliative care, within and beyond the PsyPal project.

1 1 2

PsyPal Project @psypaleu.bsky.social · Apr 15

Stay tuned for further updates on outcomes and recommendations as these ideas take root and grow. A special thank you to all participants for your insight, collaboration, and dedication. More info available on our LinkedIn: www.linkedin.com/company/psyp...
#PalliativeCare #PsychedelicTherapy

PsyPal | LinkedIn

www.linkedin.com

PsyPal Project @psypaleu.bsky.social · Apr 15

Designing the Future of Psychedelic Therapy in Palliative Care - on April 3–4, @iese.bsky.social hosted a groundbreaking Design Thinking Workshop led by the PsyPal core team, convening experts from across healthcare, policy, academia, & patient advocacy.
#ClinicalTrials #PolicyInnovation #PsyPal

PsyPal Project @psypaleu.bsky.social · Apr 11

Alongside PsyPal partner Albino Oliveira-Maia, PsyPal PI Robert Schoevers presented the current landscape of psychedelic treatments in psychiatry and emphasised the knowledge that will emerge from the PsyPal trial, which will begin recruiting shortly.

PsyPal Project @psypaleu.bsky.social · Apr 11

Delighted to feature at the European Psychiatric Association Congress last week in Madrid, hosting over 5000.
PsyPal formed part of the presidential symposium to discuss psychedelic treatments in psychiatry. A wonderful opportunity to meet leading figures in psychiatry across Europe! #EPA2025

This link will take you to a page that’s not on LinkedIn

PsyPal Project @psypaleu.bsky.social · Feb 28

Our partners, European Psychiatric Association, published this policy paper on psychedelic treatments in psychiatry. This paper highlights specific challenges, potential benefits, & practical recommendations for clinical and research use of psychedelic treatmentsl: www.cambridge.org/core/service...

PsyPal Project @psypaleu.bsky.social · Feb 21

A great resource to stay up to date with researchers in the field of psychedelics!

josh hardman @josh-hardman.bsky.social · Nov 15

I have started a 'Psychedelics Starter Pack' of Bluesky accounts related to the field.

It's very much a Work In Progress - please reply or DM with suggestions.

go.bsky.app/VNupHtA

2

PsyPal Project @psypaleu.bsky.social · Feb 21

hi @josh-hardman.bsky.social please consider adding PsyPal- we're an EU-funded study investigating the use of psilocybin therapy for individuals with palliative care needs!

This link will take you to a page that’s not on LinkedIn

PsyPal Project @psypaleu.bsky.social · Jan 30

"Treating mental illness with psychedelics?"

This article by Ana Luísa Monteiro of SIC Notícias outlines the current status of psychedelic clinical trials in Portugal and speaks to PsyPal partner, Albino Oliveira-Maia on the need for more research: amp.sicnoticias.pt/saude-e-bem-...

PsyPal Project @psypaleu.bsky.social · Jan 30

Session 1 is taking place Friday February 7 at 13-14:30 CET!

A European perspective on psychedelics research, from pharmacology to clinical effects

PsyPal Project @psypaleu.bsky.social · Jan 23

news.ki.se/a-european-perspective-on-psychedelics-research-from-pharmacology-to-clinical-effects
The Karolinska Institut will be running a series of webinars on psychedelic research in Europe, which may be of interest to our followers and supporters.
@karolinskainst.bsky.social
#euresearch

In this webinar series we will explore the wide scope of psychedelics research conducted at various centers in Europe. Throughout the sessions we will cover a wide range of topics: from pharmacology and preclinical investigations to the clinical trials conducted in psychiatry. The three sessions in this series build upon each other but can also be attended in isolation. In each session, cutting-edge research is presented by esteemed researchers from different universities in Europe.

news.ki.se

Neurobiological mechanisms of antidepressant properties of psilocybin: A systematic review of blood biomarkers

PsyPal Project @psypaleu.bsky.social · Jan 21

A recent systematic review looked at the neurobiological mechanisms of psilocybin's antidepressant properties using blood biomarkers! This review is highly informative for the PsyPal project and is notably co-authored by some of our project members.
www.sciencedirect.com/science/arti...

Psilocybin represents a novel therapeutic approach for individuals with major depressive disorder (MDD) who do not respond to conventional antidepress…

www.sciencedirect.com